Review article: 'True' re-infection of Helicobacter pylori after successful eradication - Worldwide annual rates, risk factors and clinical implications

Alimentary Pharmacology and Therapeutics

Volumn 29, Issue 2, 2009, Pages 145-160

  Zhang, Y Y ^a,b   Xia, H H X ^b   Zhuang, Z H ^c   Zhong, J ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TRANSMISSION; BACTERIUM CONTAMINATION; DEVELOPED COUNTRY; DEVELOPING COUNTRY; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INCIDENCE; INFECTION RATE; INFECTION RISK; PRIORITY JOURNAL; RECURRENT INFECTION; REINFECTION; REVIEW;

ADULT; CHILD; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; RECURRENCE; RISK FACTORS; TIME FACTORS;

EID: 57649179469     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03873.x     Document Type: Review

References (139)

1. Xia HH, Talley NJ. Natural acquisition and spontaneous elimination of Helicobacter pylori infection. Am J Gastroenterol 1997 92 : 1780 7.
2. Anonymous. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group Gut 1993 34 : 1672 6.
3. Graham DY, Malaty HM, Evans DG, et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991 100 : 1495 501.
4. Gill HH, Majmudar P, Shankaran K, et al. Age-related prevalence of Helicobacter pylori antibodies in Indian subjects. Indian J Gastroenterol 1994 13 : 92 4.
5. Sathar MA, Gouws E, Simjee AE, et al. Seroepidemiological study of Helicobacter pylori infection in South African children. Trans R Soc Trop Med Hyg 1997 91 : 393 5.
6. Perez-Perez GI, Taylor DN, Bodhidatta L, et al. Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis 1990 161 : 1237 41.
7. Li YY, Hu PJ, Du GG, et al. The prevalence of Helicobacter pylori infection in the Peoples Republic of China. Am J Gastroenterol 1991 86 : 446 9.
8. Wang KJ, Wang RT. Meta-analysis on the epidemiology of Helicobacter pylori infection in China. Zhonghua Liu Xing Bing Xue Za Zhi 2003 24 : 443 6. (Chinese)
9. Rowland M, Daly L, Vaughan M, et al. Age-specific incidence of Helicobacter pylori. Gastroenterology 2006 130 : 65 72.
10. Anonymous. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994 272 : 65 9.
11. Anonymous. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994 61 : 1 241.
12. Eslick GD, Lim LL, Byles JE, et al. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 1999 94 : 2373 9.
13. Wong BC, Lam SK, Wong WM, et al. China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004 291 : 187 94.
14. Xia HH, Yu Wong BC, Talley NJ, et al. Alternative and rescue treatment regimens for Helicobacter pylori eradication. Expert Opin Pharmacother 2002 3 : 1301 11.
15. Chey WD, Wong BC. Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007 102 : 1808 25.
16. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007 56 : 772 81.
17. Xia HX, Gilvarry J, Beattie S, et al. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens. Am J Gastroenterol 1995 90 : 1221 5.
18. Xia HH, Talley NJ, Keane CT, et al. Recurrence of Helicobacter pylori infection after successful eradication: nature, possible causes and potential preventive strategies. Digest Dis Sci 1997 42 : 1821 34. (Review)
19. Gisbert JP. The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review. Am J Gastroenterol 2005 100 : 2083 99.
20. Niv Y, Hazazi R. Helicobacter pylori recurrence in developed and developing countries: meta-analysis of 13C-urea breath test follow-up after eradication. Helicobacter 2008 13 : 56 61.
21. George LL, Borody TJ, Andrews P, et al. Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust 1990 153 : 145 9.
22. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992 116 : 705 8.
23. Bell GD, Powell KU, Burridge SM, et al. Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Q J Med 1993 86 : 743 50.
24. Schutze H, Schütze K, Hentschel E, et al. More on the eradication of Helicobacterpylori and the recurrence of duodenal ulcer. N Engl J Med 1993 329 : 1356.
25. Borody TJ, Andrews P, Mancuso N, et al. Helicobacter pylori reinfection rate, in patients with cured duodenal ulcer. Am J Gastroenterol 1994 89 : 529 32.
26. Louw JA, Lucke W, Jaskiewicz K, et al. Helicobacter pylori eradication in the African setting, with special reference to reinfection and duodenal ulcer recurrence. Gut 1995 36 : 544 7.
27. Schuetze K, Hentschel E, Dragosics B, et al. Helicobacter pylori re infection with identical organisms: transmission by the patients' spouses. Gut 1995 36 : 831 3.
28. Labenz J, Tillenburg B, Peitz U, et al. Long-term consequences of Helicobacter pylori eradication: clinical aspects. Scand J Gastroenterol Suppl 1996 215 : 111 5.
29. Goh KL, Navaratnam P, Peh SC. Reinfection and duodenal ulcer relapse in south-east Asian patients following successful Helicobacter pylori eradication: results of a 2-year follow-up. Eur J Gastroenterol Hepatol 1996 8 : 1157 60.
30. Miehlke S, Lehn N, Meining A, et al. Helicobacter pylori reinfection is rare in peptic ulcer patients cured by antimicrobial therapy. Eur J Gastroenterol Hepatol 1996 8 : 1161 3.
31. Cutler AF, Prasad VM. Long-term follow-up of Helicobacter pylori serology after successful eradication. Am J Gastroenterol 1996 91 : 85 8.
32. Abu-Mahfouz MZ, Prasad VM, Santogade P, et al. Helicobacter pylori recurrence after successful eradication: 5-year follow-up in the United States. Am J Gastroenterol 1997 92 : 2025 8.
33. Cui Y, Hu P, Chen M, et al. Helicobacter pylori reinfection and ulcer recurrence in patients with duodenal ulcer healing: a 2-year following-up in an area with high prevalence of Helicobacter pylori. Chn J Intern Med 1998 137 : 17 20. (Chinese)
34. Mitchell HM, Hu P, Chi Y, et al. A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China). Gastroenterology 1998 114 : 256 61.
35. Kim N, Lim SH, Lee KH, et al. Helicobacter pylori reinfection rate and duodenal ulcer recurrence in Korea. J Clin Gastroenterol 1998 27 : 321 6.
36. Archimandritis A, Balatsos V, Delis V, et al. "Reappearance" of Helicobacter pylori after eradication: implications on duodenal ulcer recurrence: a prospective 6 year study. J Clin Gastroenterol 1999 28 : 345 7.
37. Chen TS, Chang FY, Lee SD, et al. Recurrence of H. pylori infection and dyspeptic symptoms after successful eradication in patients cured of duodenal ulcer disease. Hepatogastroenterology 1999 46 : 252 6.
38. Rollan A, Giancaspero R, Fuster F, et al. The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country. Am J Gastroenterol 2000 95 : 50 6.
39. Hildebrand P, Bardhan P, Rossi L, et al. Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults. Gastroenterology 2001 121 : 792 8.
40. Adachi M, Mizuno M, Yokota K, et al. Reinfection rate following effective therapy against Helicobacter pylori infection in Japan. J Gastroenterol Hepatol 2002 17 : 27 31.
41. Okada M, Shirotani T, Nishimura H, et al. Recurrence of Helicobacter pylori infection and the long-term outcome of peptic ulcer after successful eradication in Japan. J Clin Gastroenterol 2002 34 : 129 34.
42. Knippig C, Arand F, Leodolter A, et al. Prevalence of H. pylori-infection in family members of H. pylori positive and its influence on the reinfection rate after successful eradication therapy: a two-year follow-up. Z Gastroenterol 2002 40 : 383 7.
43. Zhou LY, Lin SR, Shen ZY, et al. Five-year follow-up study after Helicobacter pylori eradication: reinfection and peptic ulcer status. Chn J Dig Dis 2003 4 : 45 8.
44. Leal-Herrera Y, Torres J, Monath TP, et al. High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection. Am J Gastroenterol 2003 98 : 2395 402.
45. Gomez RBJ, Rojas FM, Garcia MMJ, et al. Incidence and factors influencing on Helicobacter pylori infection recurrence. Rev Esp Enferm Dig 2004 96 : 620 3.
46. Mesquita MA, Lorena SL, Zeitune JM, et al. Recurrence of Helicobacter pylori infection after eradication therapy in Brazilian patients with peptic ulcer. J Clin Gastroenterol 2005 39 : 447.
47. Zendehdel N, Nasseri-Moghaddam S, Malekzadeh R, et al. Helicobacter pylori reinfection rate 3 years after successful eradication. J Gastroenterol Hepatol 2005 20 : 401 4.
48. McMahon BJ, Bruce MG, Hennessy TW, et al. Reinfection after successful eradication of Helicobacter pylori: a 2-year prospective study in Alaska Natives. Aliment Pharmacol Ther 2006 23 : 1215 23.
49. Cheon JH, Kim N, Lee DH, et al. Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea. Eur J Gastroenterol Hepatol 2006 18 : 515 9.
50. Cameron EA, Bell GD, Baldwin L, et al. Long-term study of re-infection following successful eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 2006 23 : 1355 8.
51. Gisbert JP, Luna M, Gómez B, et al. Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients. Aliment Pharmacol Ther 2006 23 : 713 9.
52. Thong-Ngam D, Mahachai V, Kullavanijaya P. Incidence of Helicobacter pylori recurrent infection and associated factors in Thailand. J Med Assoc Thai 2007 90 : 1406 10.
53. Ahmad MM, Ahmed DS, Rowshon AH, et al. Long-term re-infection rate after Helicobacter pylori eradication in Bangladeshi adults. Digestion 2007 75 : 173 6.
54. Kato S, Abukawa D, Furuyama N, et al. Helicobacter pylori reinfection rates in children after eradication therapy. J Pediatr Gastroenterol Nutr 1998 27 : 543 6.
55. Farrell S, Milliken I, Doherty GM, et al. Total family unit Helicobacter pylori eradication and pediatric re-infection rates. Helicobacter 2004 9 : 285 8.
56. Halitim F, Vincent P, Michaud L, et al. High rate of Helicobacter pylori reinfection in children and adolescents. Helicobacter 2006 11 : 168 72.
57. Xia HX, Windle HJ, Marshall DG, et al. Recrudescence of Helicobacter pylori after apparently successful eradication. Novel application of randomly amplified polymorphic DNA fingerprinting. Gut 1995 37 : 30 4.
58. Van der Hulst RW, Rauws EA, Köycü B, et al. Helicobacter pylori reinfection is virtually absent after successful eradication. J Infect Dis 1997 176 : 196 200.
59. Gisbert JP, Arata IG, Boixeda D, et al. Role of partner's infection in reinfection after Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 2002 14 : 865 71.
60. Okimoto T, Murakami K, Sato R, et al. Is the recurrence of Helicobacter pylori infection after eradication therapy resultant from recrudescence or reinfection, in Japan. Helicobacter 2003 8 : 186 91.
61. Soto G, Bautista CT, Roth DE, et al. Gastrointestinal Physiology Working Group in Peru. Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy. J Infect Dis 2003 188 : 1263 75.
62. Wheeldon TU, Hoang TT, Phung DC, et al. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome. Aliment Pharmacol Ther 2005 21 : 1047 53.
63. Costas M, Owen RJ, Bickley J, Morgan DR. Molecular techniques for studying the epidemiology of infection by Helicobacter pylori. Scand J Gastroenterol 1991 181 : 20 32.
64. Owen RJ, Bickley J, Costas M, et al. Genomic variation in Helicobacter pylori: application to identifi cation of strains. Scand J Gastroente rol 1991 26 : 43 50.
65. Tee W, Lambert J, Smallwood R, et al. Ribotyping of Helicobacter pylori from clinical specimens. J Clin Microbiol 1992 30 : 1562 7.
66. Salama SM, Jiang Q, Chang N, et al. Characterization of chromosomal DNA profiles from Helicobacter pylori strains isolated from sequential gastric biopsy specimens. J Clin Microbiol 1995 33 : 1496 7.
67. Marshall DG, Coleman DC, Sullivan DJ, et al. Genomic DNA fingerprinting of clinical isolates of Helicobacter pylori using short oligonucleotide probes containing repetitive sequences. J Appl Bacteriol 1996 81 : 509 17.
68. Akopyanz N, Bukanov NO, Westblom TU, et al. DNA diversity among clinical isolates of Helicobacter pylori dete cted by PCR based RAPD fingerprinting. Nucleic Acids Res 1992 20 : 5137 42.
69. Taylor NS, Fox JG, Akopyants NS, et al. Long-term colonization with single and multiple strains of Helicobacter pylori assesse d by DNA fingerprinting. J Clin Mirobiol 1995 33 : 918 23.
70. Langenberg W, Rauws EA, Houthoff HJ, et al. Follow-up study of individuals with untreated Campylobacter pylori- associated gastritis and of noninfected persons with nonulcer dyspepsia. J Infect Dis 1988 157 : 1245 9.
71. Oudbier JH, Langenberg W, Rauws EAJ, et al. Genotypical variation of Campylobacter pylori from gastric mucosa. J Clin Microbiol 1990 28 : 559 65.
72. Taylor DE, Eaton M, Chang N, et al. Construction of a Helicobacter pylori genome map and demonstration of diversity at the genome level. J Bacteriol 1992 174 : 6800 6.
73. Prewett EJ, Owen RJ, Pounder RE. DNA patterns of Helicobacter pylori isolated from gastric, antrum, body, and duodenum. Gastroenterology 1992 102 : 829 33.
74. Fujimoto S, Marshall B, Blaser MJ. PCR-based restriction fragment length polymorphism typing of Helicobacter pylori. J Clin Microbiol 1994 32 : 331 4.
75. Hurtado A, Owen RJ. Identification of mixed genotypes in Helicobacter pylori from gastric biopsy tissue by analysis of urease gene polymorphisms. FEMS Immunol Med Microbiol 1994 8 : 307 14.
76. Hirschl AM, Richter M, Makristathis A, et al. Single and multiple strain colonization in patients with Helicobacter pylori- associated gastritis: detection by macrorestriction DNA analysis. J Infect Dis 1994 170 : 473 5.
77. Beji A, Vincent P, Darchis I, Hussn MO, Cortot A, Leclerc H. Evidence of gastritis with several Helicobacter pylori strains. Lancet 1989 2 : 1402 3.
78. Owen RJ, Owen RJ, Bickley J, et al. Comparison of PCR-based restriction length polymorphism analysis of urease gene s with rRNA gene profiling for monitoring Helicobacter pylori infections in patients on triple therapy. J Clin Microbiol 1994 32 : 1203 10.
79. Fraser AG, Bickley J, Owen RJ, et al. DNA fingerprints of Helicobacter pylori before and after treatment with omeprazole. J Clin Pathol 1992 45 : 1062 5.
80. Jeen YT, Lee SW, Kwon SI, et al. Differentiation between reinfection and recrudescence of Helicobacter pylori strains using PCR-based restriction fragment length polymorphism analysis. Yonsei Med J 2001 42 : 41 5.
81. Bell GD, Powell KU, Burridge SM, et al. Reinfection or recrudescence after apparently successful eradication of Helicobacter pylori infection; implications for treatment of patients with duodenal ulcer disease. Q J Med 1993 86 : 375 82.
82. Malaty HM, Engstrand L, Pederson NL, et al. Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med 1994 120 : 982 6.
83. Graham DY, Malaty HM, Go MF. Are there susceptible hosts to Helicobacter pylori infection? Scand J Gastroenterol 1994 29 : 6 10.
84. Azuma T, Konish J, Tanaka Y, et al. Contribution of HLA-DQA gene to hosts response against H. pylori. Lancet 1994 343 : 542 3.
85. Smith AW, Aathithan S, Power EGM, et al. Blood group antigens and Helicobacter pylori infections. Lancet 1994 343 : 543.
86. Azuma T, Ito S, Kato T, et al. Association between HLA-DQA1 gene polymorphism and susceptibility or resistance to Helicobacter pylori. Am J Gastroenterology 1994 89 : 1300.
87. Uno M, Hamajima N, Ito LS, et al. Helicobacter pylori seropositivity and IL-1B C-31T polymorphism among Japanese Brazilians. Int J Mol Med 2002 10 : 321 6.
88. Hamajima N, Katsuda N, Matsuo K, et al. High anti-Helicobacter pylori antibody seropositivity associated with the combination of IL-8-251TT and IL-10-819TT genotypes. Helicobacter 2003 8 : 105 10.
89. Hamajima N, Shibata A, Katsuda N, et al. Subjects with TNF-A-857TT and -1031TT genotypes showed the highest Helicobacter pylori seropositive rate compared with those with other genotypes. Gastric Cancer 2003 6 : 230 6.
90. Ikehara Y, Nishihara S, Yasutomi H, et al. Polymorphisms of two fucosyltransferase genes (Lewis and Secretor genes) involving type I Lewis antigens are associated with the presence of anti-Helicobacter pylori IgG antibody. Cancer Epidemiol Biomarkers Prev 2001 10 : 971 7.
91. Oba-Shinjo SM, Uno M, Ito LS, et al. Association of Lewis and Secretor gene polymorphisms and Helicobacter pylori seropositivity among Japanese-Brazilians. J Gastroenterol 2004 39 : 717 23.
92. Enroth H, Engstrand L. Immunomagnetic separation and PCR for detection of Helicobacter pylori in water and stool specimens. J Clin Microbiol 1995 33 : 2162 5.
93. Hulten K, Han SW, Enroth H, et al. Helicobacter pylori in the drinking water in Pe ru. Gastroenterology 1996 110 : 1031 5.
94. Klein PD, Graham DY, Gaillour A, et al. Water source as risk factor of Helicobacter pylori infection in Peruvian children. Lancet 1991 337 : 1503 6.
95. Hopkins RJ, Vial PA, Ferreccio C, et al. Seroprevalence of Helicobacter pylori in Chile: vegetable s may serve as one route of transmission. J Infect Dis 1993 168 : 222 6.
96. Harris AW, Douds A, Meurisse V, et al. Seroprevalence of Helicobacter pylori in residents of a hospital for people with severe learning difficulties. Eur J Gastroenterol Hepatol 1995 7 : 21 3.
97. Lambert JR, Lin S-K, Sievert W, et al. High prevalence of Helicobacter pylori antibodies in an institutionalized population: evidence for person-to-person transmission. Am J Gastroenterol 1995 90 : 2167 71.
98. Hammermeister I, Janus G, Schamarovski F, et al. Elevated risk of Helicobacter pylori infection in submarine crews. Eur J Clin Microbiol Infect Dis 1992 11 : 9 14.
99. Mitchell HM, Lee A, Carrick J. Increase d incidence of Campylobacter pylori infection in gastroenterologists: further evidence to support person-to-person transmission of C. pylori. Scand J Gastroenterol 1989 24 : 396 400.
100. Wilhoite SL, Ferguson DA Jr., Soike DR, et al. Increased prevalence of Helicobacter pylori antibodies among nurses. Arch Intern Med 1993 153 : 707 12.
101. Vincent P, Gottrand F, Pernes P, et al. Helicobacter pylori infection in cohabiting children. Lancet 1991 337 : 848.
102. Vincent P, Gottrand F, Pernes P, et al. High prevalence of Helicobacter pylori infection in cohabiting children. Epidemiology of a cluster, with special emphasis on molecular typing. Gut 1994 35 : 313 6.
103. Drumm B, Guillermo MB, Prez-Prez I, et al. Intrafamilial clustering of Helicobacter pylori infection. N Engl J Med 1990 322 : 359 63.
104. Mitchell HM, Bohane TD, Berkowicz J, et al. Antibody to Campylobacter pylori in families of index children with gastrointestinal illness due to C. pylori. Lancet 1987 2 : 681 2.
105. Malaty HM, Graham DY, Klein PD, et al. Transmission of Helicobacter pylori infection: studies in families of healthy individuals. Scand J Gastroenterol 1991 26 : 827 32.
106. Dominici P, Bellentani S, Di Biase AR, et al. Familial clustering of Helicobacter pylori infection: population based study. BMJ 1999 319 : 537 40.
107. Wang JT, Sheu JC, Lin JT, et al. Direct DNA amplification and restriction pattern analysis of Helicobacter pylori in patients with duodenal ulcer and their families. J Infect Dis 1993 168 : 1544 8.
108. Bamford KB, Bickley J, Collins JSA, et al. Helicobacter pylori: comparison of DNA fingerprints provides evidence for intrafamilial infection. Gut 1993 34 : 1348 50.
109. Majewski SI, Goodwin CS. Restriction endonuclease analysis of the genome of Campylobacter pylori with a rapid extraction method: Evidence for considerable genomic variation. J Infect Dis 1988 157 : 465 71.
110. Weyermann M, Adler G, Brenner H, et al. The mother as source of Helicobacter pylori infection. Epidemiology 2006 17 : 332 4.
111. Shimizu T, Yarita Y, Kaneko K, et al. Case of intrafamilial Helicobacter pylori reinfection after successful eradication therapy. Pediatr Infect Dis J 2000 19 : 901 3.
112. Konno M, Fujii N, Yokota S, et al. Five-year follow-up study of mother-to-child transmission of Helicobacter pylori infection detected by a random amplified polymorphic DNA fingerprinting method. J Clin Microbiol 2005 43 : 2246 50.
113. Langenberg W, Rauws EAJ, Oudbier JH, et al. Patient-to-patient transmission of Campylobacter pylori infection by fiberoptic gastroduodenoscopy and biopsy. J Infect Dis 1990 161 : 507 11.
114. Roosendaal R, Kuipers EJ, Van den Brule AJ, et al. Importance of the fiberoptic endoscope cleaning procedure for detection of Helicobacter pylori in gastric biopsy specimens by PCR. J Clin Microbiol 1994 32 : 1123 6.
115. Fantry GT, Zheng QX, James SP. Conventional cleaning and disinfection techniques eliminate the risk of endoscopic transmission of Helicobacter pylori. Am J Gastroenterol 1995 90 : 227 32.
116. Malaty HM, El-Kasabany A, Graham DY, et al. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 2002 359 : 931 5.
117. Sinha SK, Martin B, Gold BD, et al. The incidence of Helicobacter pylori acquisition in children of a Canadian First Nations community and the potential for parent-to-child transmission. Helicobacter 2004 9 : 59 68.
118. Rothenbacher D, Bode G, Brenner H. Dynamics of Helicobacter pylori infection in early childhood in a high-risk group living in Germany: loss of infection higher than acquisition. Aliment Pharmacol Ther 2002 16 : 1663 8.
119. Xia HH, Wong WM, Chan OO, et al. Natural acquisition of Helicobacter pylori in adult dyspeptic patients with or without previous infection - a 7-year follow-up study. J Gastroenterol Hepatol 2005 20 : A112.
120. Chui SY, Clay TM, Lyerly HK, et al. The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori. Cancer Epidemiol Biomarkers Prev 2005 14 : 1883 9.
121. Wilson KT, Crabtree JE. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology 2007 133 : 288 308.
122. Marshall B, Schoep T. Helicobacter pylori as a vaccine delivery system. Helicobacter 2007 12 : 75 9.
123. Aebischer T, Walduck A, Schroeder J, et al. A vaccine against Helicobacter pylori: towards understanding the mechanism of protection. Int J Med Microbiol 2008 298 : 161 8.
124. DiPetrillo MD, Tibbetts T, Kleanthous H, et al. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers. Vaccine 1999 18 : 449 59.
125. Michetti P, Kreiss C, Kotloff KL, et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 1999 116 : 804 12.
126. Angelakopoulos H, Hohmann EL. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect Immun 2000 68 : 2135 41.
127. Bumann D, Metzger WG, Mansouri E, et al. Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine 2001 20 : 845 52.
128. Kotloff KL, Sztein MB, Wasserman SS, et al. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect Immun 2001 69 : 3581 90.
129. Losonsky GA, Kotloff KL, Walker RI. B cell responses in gastric antrum and duodenum following oral inactivated Helicobacter pylori whole cell (HWC) vaccine and LT(R192G) in H pylori seronegative individuals. Vaccine 2003 21 : 562 5.
130. Kabir S. The current status of Helicobacter pylori vaccines: a review. Helicobacter 2007 12 : 89 102.
131. Lehours P, Yilmaz O. Epidemiology of Helicobacter pylori infection. Helicobacter 2007 12 : 1 3.
132. Xia HH, Phung N, Altiparmak E, et al. Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in western Sydney between 1990 and 1998. Digest Dis Sci 2001 46 : 2716 23.
133. Rehnberg-Laiho L, Rautelin H, Koskela P, et al. Decreasing prevalence of helicobacter antibodies in Finland, with reference to the decreasing incidence of gastric cancer. Epidemiol Infect 2001 126 : 37 42.
134. Jacobson K. The changing prevalence of Helicobacter pylori infection in Canadian children: should screening be performed in high-risk children? Can J Gastroenterol 2005 19 : 412 4.
135. Xia B, Xia HH, Ma CW, et al. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong. Aliment Pharmacol Ther 2005 22 : 243 9.
136. Ho KY, Chan YH, Kang JY. Increasing trend of reflux esophagitis and decreasing trend of Helicobacter pylori infection in patients from a multiethnic Asian country. Am J Gastroenterol 2005 100 : 1923 8.
137. Manuel D, Cutler A, Goldstein J, et al. Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease-related complications. Aliment Pharmacol Ther 2007 25 : 1423 7.
138. Goh KL. Changing trends in gastrointestinal disease in the Asia-Pacific region. J Dig Dis 2007 8 : 179 85.
139. Rupnow MF, Shachter RD, Owens DK, et al. Quantifying the population impact of a prophylactic Helicobacter pylori vaccine. Vaccine 2001 20 : 879 85.